About CRC

Founded in 2006, Cognitive Research Corporation (CRC) is a privately-held, full-service CRO specialized in CNS and early phase product development. With offices in Florida and relationships with experienced research facilities around the country, CRC is well-positioned to conduct clinical studies at any stage, Phase I-IV. CRC provides services that are comprehensive, flexible, quality-driven and cost-effective. Its focus is on providing a seamless extension of your organization, allowing you to reach your goals in a timely, efficient manner.

With a unique depth of expertise in CNS populations and healthy subject protocols, the CRC team has decades of experience in successfully conducting clinical trials. CRC brings deep expertise in trial design and protocol development, clinical trial management, data management, biostatistics, and other CRO services, combined with responsiveness, creativity, and a commitment to excellence.

In addition to CRO services, CRC has developed proprietary technologies, including sophisticated neuropsychological assessment and state-of-the-art simulation technologies which they apply in a broad range of studies.

Download the CRC fact sheet.

Download a presentation about CRC’s capabilities.

Tom Hochadel, Pharm.D.
CEO
Gary Kay, Ph.D.
President, CSO

CRC’s Relationship with Clinical Trial Centers Alliance

In many instances, sponsors request a streamlined solution to meet CRO + site deliverables under one contract. Based on our longstanding relationship with the founders of CRC, we’ve successfully collaborated to conduct healthy and patient population studies as an integrated team. Our partnership is by no means exclusive, as we continue to work with all CROs, but we are able to offer a bundled option when advantageous to sponsors. As with our Alliance research sites, CRC is an independent entity – not part of an SMO or financially linked with our sites.

Proprietary Psychometric Technologies

CRC Driving Simulator (CRCDS)
CRC is the exclusive provider of the state-of-the-art PC-based driving simulator, the CRCDS MiniSim. Fully validated for multicenter clinical trials, the CRCDS is used to evaluate the effects of a wide variety of drugs on the driving performance of healthy and patient populations. The CRCDS has been used in more than 20 clinical trials for the pharmaceutical industry and regulatory agencies.

Download the CRCDS fact sheet.

CogScreen®
CogScreen® is a computerized cognitive test battery developed by Dr. Gary Kay and his colleagues. It is used globally in aerospace psychology and psychopharmacology research.

CRCDS Publications:

Journal of Clinical Pharmacy and Therapeutics – May 10, 2020
An assessment of the centrally acting muscle relaxant tolperisone on driving ability and cognitive effects compared to placebo and cyclobenzaprine

Human Psychopharmacology: Clinical and Experimental – April 22, 2017
Next-day residual effects of flibanserin on simulated driving performance in premenopausal women

Human Psychopharmacology: Clinical and Experimental – February 16, 2016
Next-day residual effects of gabapentin, diphenhydramine, and triazolam on simulated driving performance in healthy volunteers: a phase 3, randomized, double-blind, placebo-controlled, crossover trial

 

For more information or to further discuss your study needs please contact:
Bobbie Theodore, M.S.
Alliance Executive Director
(916) 803-7149
bobbie@alliancesites.com